The role of plasma exchange in treatment of myasthenia gravis.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000096:biosynthesis; D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000276:immunology / Q000628:therapy*; D010951:Plasma Exchange; D013945:Thymoma / Q000150:complications / Q000601:surgery; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D001379:Azathioprine